Nova Eye Medical Limited

Equities

EYE

AU0000094252

Market Closed - Australian S.E. Other stock markets 06:58:32 05/06/2026 BST			5-day change	1st Jan Change
0.1175 ^AUD	-2.08%		+6.82%	-11.32%

05-05	Nova Eye Medical Limited, Nine Months 2026 Earnings Call, May 05, 2026
05-05	Nova Eye Medical upgrades fy26 sales guidance (ex-China) to $22-23 million	RE

Transcript : Nova Eye Medical Limited, 2025 Sales/ Trading Statement Call, Jul 09, 2025

Published on 07/09/2025 at 03:35 am BST - Modified on 07/09/2025 at 04:50 am BST

S&P Capital IQ

Presenter Speech
Mark Flynn (Executives)

Good morning, everyone, and welcome and thank you for joining us for today's Nova Eye Medical Investor Webinar. My name is Mark Flynn, and I look after Investor

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Nova Eye Medical Limited

05-05	Nova Eye Medical Limited, Nine Months 2026 Earnings Call, May 05, 2026
05-05	Nova Eye Medical upgrades fy26 sales guidance (ex-China) to $22-23 million	RE
05-05	Nova Eye Medical Limited Upgrades Sales Guidance for the Fiscal Year 2026	CI
05-05	Nova Eye Medical Limited Reports Group Sales Results for the Twelve-Month Ended 30 April 2026	CI
03-03	Nova Eye Medical Limited - Shareholder/Analyst Call
03-03	Nova Eye Medical says EU MDR certification achieved for Nova Eye's iTrack product portfolio	RE
02-25	Nova Eye Medical Limited Reaffirms Earnings Guidance for the Year 2026	CI
02-25	Nova Eye Medical Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
02-02	Nova Eye Medical Limited, Q2 2026 Earnings Call, Feb 02, 2026
01-29	Nova Eye Medical posts December quarter sales of $6.1 million	RE
01-27	Nova Eye Medical Says Statistical Report Backs Efficacy, Safety of Eye Surgery Device; Shares Up 3%	MT
01-19	Nova Eye Medical Limited, H1 2026 Sales/ Trading Statement Call, Jan 19, 2026
01-12	Nova Eye Medical posts December quarter global sales of $6.1 million	RE
01-11	Nova Eye Medical Limited Reports Unaudited Group Sales Results for the Quarter, Six Months and the Twelve Months Ended 31 December 2025	CI
11-25	Nova Eye Medical Limited - Special Call